Displaying 655 (all) recruiting clinical trials.
-
Person-Centered Quality Measurement and Management in a System for Addictions Treatment in New York State (Project 3)
To drive change, OASAS will invest in a quality measurement and management (QM2) strategy that provides performance feedback to activate leadership and staff of clinics ... -
SOAR: Smartphones for Opiate Addiction Recovery
Treatments for opioid addiction exist, but effectiveness is compromised when subjects use illicit opiates during treatment. Reuse rates during treatment can be high, and reducing ... -
A Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Volixibat in the Treatment of Cholestatic Pruritus in Patients with Primary Sclerosing Cholangitis (VISTAS)
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, single, inferentially seamless, adaptive design clinical study that will be conducted in 3 parts. The primary and ... -
Development of digital biomarkers and advanced data analytics in neurosurgery
Development of a neurosurgical disease digital biomarkers' signature to help to diagnose, monitor, manage and predict disease course -
A Single-Center Observational Study of the Pre-Operative and Post-Operative Corneal Endothelial Cell Density of Patients Undergoing Glaucoma Surgery
This study aims to investigate corneal endothelial cell migration and healing after glaucoma surgery using non-contact specular microscopy and tomography. Eighty patients undergoing glaucoma surgery ... -
A Digital Health Framework To Assess Glycemia and Physical Activity in Kidney Transplant Recipients
This pilot is a prospective exploratory study in 20 patients 50 years of age or older with no cognitive impairments who are scheduled to receive ... -
A Phase 2 Multicenter Randomized Double-blind Placebo-controlled Study to Evaluate the Safety Tolerability Pharmacokinetics and Efficacy of TTI-101 in Participants with Idiopathic Pulmonary Fibrosis
This multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical study is designed to evaluate the safety and tolerability of 3 dose levels of TTI-101 vs placebo in ... -
A Multicenter Randomized Double-Blind Placebo-Controlled Non-inferiority Crossover Study Evaluating the Safety and Immunogenicity of the Herpes Zoster Subunit Vaccine in Patients with Systemic Lupus Erythematosus
This randomized, double-blind, placebo-controlled, non-inferiority crossover study will evaluate the HZ/su vaccine in SLE patients in order to evaluate safety and immunogenicity in patients ... -
REBYOTA for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
This is a prospective observational cohort study designed to collect data on patients who received REBYOTA for the prevention of rCDI in the routine care ... -
Glycemic and Cardiometabolic Biomarker improvements associated with reduction in air pollution exposure
In this research, we will conduct a double-blind, sham-controlled, randomized trial to examine the glycemic and cardiometabolic impact of air pollution exposure reduction using home ...